openPR Logo
Press release

Amnesia Market Growth: $3.5B in 2024 to $6.7B by 2034

12-03-2025 03:19 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Exactitude Consultancy

Amnesia Market

Amnesia Market

The Amnesia market is set to expand at a CAGR of 6.8%, driven by growing prevalence of neurological disorders and advances in diagnostic and treatment options.

Introduction:
The Amnesia Market is projected to grow significantly, reaching a market value of $6.7 billion by 2034, up from $3.5 billion in 2024. This growth is driven by an increase in neurological disorders, advancements in cognitive treatments, and a growing demand for cognitive training devices, which are expected to revolutionize the care and management of amnesia.

Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/72856

Key Takeaways:
• Market Size & Forecast:
o 2024: $3.5 billion
o 2034: $6.7 billion
o CAGR: 6.8%

• The market's growth is fueled by increasing incidences of amnesia and related neurological conditions, along with advancements in AI-driven diagnostic tools.

Key Players in the Market:
• Eli Lilly
• Novartis
• Pfizer
• Merck & Co.
• Johnson & Johnson
• Biogen
• Cerevel Therapeutics
Key Events in the Last 5 Years:
1. Increased Diagnosis and Awareness: Rising awareness around neurological conditions has led to better diagnoses and a larger patient pool.
2. Technological Advancements: AI and neuroimaging technologies have advanced significantly, improving diagnostic accuracy and patient management.
3. Research and Development: Continued investment in pharmaceutical R&D to develop innovative treatments for neurological disorders linked to amnesia.
Explore Full Report here:
https://exactitudeconsultancy.com/reports/72856/amnesia-market

Market Growth Rate (CAGR & Forecast):
The Amnesia Market is expected to grow at a CAGR of 6.8% from 2025 to 2034. The demand for effective diagnostics, treatment solutions, and cognitive rehabilitation tools are key contributors to this growth.
Market Segments and Their Growth Analysis:
• By Product Type:
o Pharmaceuticals
o Cognitive Training Devices

• By Application:
o Diagnosis
o Treatment

• By End-User:
o Hospitals
o Clinics

• By Technology:
o Neuroimaging
o Artificial Intelligence

• By Distribution Channel:
o Online
o Offline
Get Your Exclusive Offer with up to 10% Discount
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=72856

Key Market Drivers:
1. Prevalence of Neurological Disorders: The rise in age-related neurological disorders is fueling the demand for amnesia treatments and care.
2. Advancements in Technology: AI, neuroimaging, and cognitive training devices are improving both diagnosis and patient outcomes.
3. Increased Health Awareness: Growing awareness about amnesia and its related conditions among the general population is encouraging early diagnoses and treatments.

Conclusion:
The Amnesia Market is expected to see rapid growth, reaching a market value of $6.7 billion by 2034, with significant technological and medical advancements propelling the market forward. The increasing demand for specialized care and new treatment options will continue to drive the market, creating a wealth of opportunities for healthcare providers and technology companies alike.

Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/72856

Our More Reports:

Niemann-Pick Disease Market
https://exactitudeconsultancy.com/reports/72880/niemann-pick-disease-market

Biologics Contract Research Organization Market
https://exactitudeconsultancy.com/reports/72882/biologics-contract-research-organization-market

Hypertrophic Cardiomyopathy Market
https://exactitudeconsultancy.com/reports/72884/hypertrophic-cardiomyopathy-market

Graft versus Host Disease (GvHD) Market
https://exactitudeconsultancy.com/reports/72886/graft-versus-host-disease-gvhd-market

https://bulletin.exactitudeconsultancy.com/

https://www.thehealthanalytics.com/

https://www.analytica.global/

https://www.marketintelligencedata.com/

https://www.marketinsightsreports.com/

Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com

About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Amnesia Market Growth: $3.5B in 2024 to $6.7B by 2034 here

News-ID: 4299116 • Views:

More Releases from Exactitude Consultancy

Pharma Contract Research Organization (CRO) Services Market Growth: $52B in 2024 to $85B by 2034
Pharma Contract Research Organization (CRO) Services Market Growth: $52B in 2024 …
The Pharma CRO Services market is expected to witness a robust CAGR of 6.1% from 2024 to 2034, driven by increased demand for outsourcing and rising drug development complexities. Introduction: The global Pharma Contract Research Organization (CRO) Services Market is projected to grow significantly, reaching $85 billion by 2034, up from $52 billion in 2024. This growth is primarily driven by the outsourcing trend within the pharmaceutical industry, the increasing complexity of
Neuroendocrine Breast Tumor Market to Reach USD 4.5 Billion by 2034, Growing at a CAGR of 7.5%
Neuroendocrine Breast Tumor Market to Reach USD 4.5 Billion by 2034, Growing at …
Exactitude Consultancy's new report explores the growth of the Neuroendocrine Breast Tumor Market, driven by advancements in diagnostic methods, targeted therapies, and increasing research investments. Introduction: Exactitude Consultancy's latest market research report on the Neuroendocrine Breast Tumor Market forecasts strong growth from USD 2.3 billion in 2024 to USD 4.5 billion by 2034, growing at a CAGR of 7.5%. The market is driven by improvements in diagnostic technologies, increasing research into targeted
Cutaneous Lupus Market to Reach USD 2.6 Billion by 2034, Growing at a CAGR of 8.1%
Cutaneous Lupus Market to Reach USD 2.6 Billion by 2034, Growing at a CAGR of 8. …
Exactitude Consultancy's new report explores the increasing growth of the Cutaneous Lupus Market, driven by advancements in treatment options, diagnostic tools, and rising awareness. Introduction: Exactitude Consultancy's latest market research report on the Cutaneous Lupus Market forecasts significant growth from USD 1.2 billion in 2024 to USD 2.6 billion by 2034, growing at a CAGR of 8.1%. The market is driven by improvements in treatment strategies, increasing awareness of cutaneous lupus, and
Respiratory Syncytial Virus Prophylaxis Market to Reach USD 12 Billion by 2034, Growing at a CAGR of 9.5%
Respiratory Syncytial Virus Prophylaxis Market to Reach USD 12 Billion by 2034, …
Exactitude Consultancy's new report analyzes the Respiratory Syncytial Virus Prophylaxis Market, driven by advancements in monoclonal antibodies, vaccines, and preventive care strategies. Introduction: Exactitude Consultancy's latest report on the Respiratory Syncytial Virus Prophylaxis Market forecasts significant growth from USD 5.4 billion in 2024 to USD 12 billion by 2034, growing at a CAGR of 9.5%. The market is driven by increasing awareness, advancements in monoclonal antibody-based prophylaxis, and rising demand for vaccines

All 5 Releases


More Releases for Amnesia

Amnesia Market to Reach USD 8.9 Billion by 2034, Expanding Growing at 6.6% CAGR
Introduction Amnesia, characterized by partial or complete memory loss, can result from brain injury, stroke, dementia, psychological trauma, substance abuse, or neurodegenerative diseases such as Alzheimer's. While traditionally associated with aging, amnesia is increasingly recognized across all age groups due to traumatic brain injuries, mental health disorders, and substance-related complications. Growing awareness of neurological health, advances in neuroimaging, and the rise of cognitive rehabilitation therapies are driving innovation in this space. Pharmaceutical
The Amnesia Release "A Tale of Bloody Moonlight"
The Ammesia - A Tale of Bloody Moonlight. A gothic and visionary debut album Image: https://www.globalnewslines.com/uploads/2025/08/f275253ca9999ce34f37e3b15f5b5080.jpg "A Tale of Bloody Moonlight," the official debut album by The Amnesia, a young band from Bologna, is now available on all major digital platforms. Released by Too Loud Records, the album blends dark, emo, and alternative sounds into an intense concept work. Born from the desire to tell a gothic story full of pathos and
J Shap Releases New Track "Amnesia" as Part of 2025 Monthly Single Series
Rising hip-hop artist Jonathan Shapiro, better known as J Shap, announces the release of "Amnesia," his latest single since signing with Survival 7 Music. He continues to build momentum with monthly releases while working toward his debut album. Image: https://www.globalnewslines.com/uploads/2025/05/c993c7ed83ab3dc51b85f142a5c0df40.jpg J Shap's music resonates with authenticity and purpose, establishing him as a voice to watch in the hip-hop community. His work continues to draw attention for its thoughtful lyricism and innovative approach
Amnesia Market Size, Epidemiology, Analysis & Trends 2023-2033
Amnesia Market Report Overview:   Report Attribute Details Base Year 2022 Forecast Years
RIVETING PAGE TURNER EXPLORES MYSTERY, INTRIGUE, AND AMNESIA
Carol L. Ochadleus has released her novel, Death & Other Lies through Zimbell House Publishing company. Early reviews have praised the captivating nature of the story, which depicts a thrilling mystery through the lens of international intrigue and amnesia. Matt Errington’s girlfriend, Kate, is missing. What’s worse: there is no record of her having existed at all. Seeking answers, Matt travels to Wales. But then, tragedy strikes. He wakes up
Amnesia Diagnostics and Therapeutics Market 2019- Ability to Memorize Data such …
MarketResearchReports.Biz is providing you Retail Market Research report of "Amnesia Diagnostics and Therapeutics Market - Global Industry Trend Analysis 2012 to 2017 and Forecast 2017 - 2025". Amnesia, also known as amnestic syndrome is a medical condition in which patients lose their ability to memorize data such as information, facts and experiences. People suffering from amnesia are generally lucid and have a sense of self but face trouble in forming new